Much Ado about . . . Something?

While utilization of upper-level visit codes will continue to increase, risk will likely remain stable.,

There has been so much in the way of education, discussions, arguments, comments, compliments, and complaints about the 2021 evaluation and management (E&M) guidelines that it gets to be a bit overwhelming. And now, there are a lot of questions about efficacy, and whether practices are abiding by the new guidelines. As a computational statistician, I am particularly interested in how the shifts over the last two years impact audit risk and target identification – specifically, how they impact the predictive algorithms used by the government, private payors, and folks like me. 

To study this, I relied upon both the utilization patterns and audit results of near-time data obtained from a base of around 40,000 physicians. I looked at all office visit utilization for 2019, 2020, and the first half of 2021; this totaled around 68 million visits. Then I looked at the audit results for those same providers across the cohort of those office visits, which totaled around 90,000 audits. 

The first thing to note was the significant reduction in the reporting of E&M codes overall for 2020, compared to 2019. In fact, for this provider population, we saw a reduction of just shy of 36 percent. Without doing primary research, it is difficult to form a cause-and-effect opinion; however, I am pretty confident that the public health emergency (PHE) played a huge role. We all heard anecdotal stories about how the lockdown prevented patients from visiting their primary care physicians, and even after restrictions were eased, people were reluctant to visit their providers, except for the most urgent of health matters. Harvard School of Public health did a great study on this in May 2020; however, it lacks the benefit of a more recent analysis and a more robust lookback. Irrespective, they showed that beginning in March, there was a precipitous drop-off of visits to providers, and while telehealth helped to reverse some of that, there was a several-month delay until the impact began to kick in. This is probably because, while telehealth wasn’t new, it also wasn’t overly popular, and it took time for many practices to gear up for the HIPAA technology requirements. 

Interestingly, while the raw volume dropped off, there wasn’t much of a significant change in utilization distribution for most codes, as shown in the table below:

Utilization Distribution

In fact, with the exception of the two lower-level codes for each category, which had the lowest utilization, distribution ratios were fairly stable.

For 2021, the annualized volume was pretty close to that of 2020. Unfortunately, the Centers for Medicare & Medicaid Services (CMS) is a bit behind on the release of the full Medicare database, and as such, I can’t compare our physician cohort against the full complement of physicians reporting to CMS. Part of this may, again, be due to the fact that even though some restrictions started to relax near the end of 2020, it took some time to change behaviors, which likely just started to occur during the first quarter of 2021. This time, however, I did see a more significant shift in utilization, particularly among codes 99204, 99205, and 99215. And again, for reasons I don’t understand, there was a precipitous increase in 99211 and 99212. I am certainly open to ideas about why use of those lower-level codes is on the rise. 

What did surprise me was that the ratio of new office visits to established office visits remained very stable across all three years (19.46, 21.58, and 21.85 percent, respectively). I really expected to see a drop-off in new office visits, as many practices were taking new patients, but alas, it was a poor assumption on my part. The table below shows the bigger picture for utilization variance year over year.

utilization distribution

There has been general reporting, including by me, that there has been an increase in distribution of the higher-level E&M codes, such as 99214, 99204, and 99205.

One question that many providers have asked me is this: how does that impact risk assessment? Well, first of all, I think it’s important to note that there is simply not enough data yet (meaning contractor audit results) to build an effective predictive model. We are, however, getting close, and I expect that by the end of the year, I will have enough data to accomplish this. In the meantime, a proxy for that is to analyze internal audit results. And that’s what I did. As noted, I looked at the results of nearly 90,000 audits for office visits. These were performed by the staff for the same providers that reported utilization. Because 99201 made up a relatively small percentage of overall utilization, and because 99201 was eliminated in 2021, I excluded it from my analysis. 

Focusing on the upper-level codes (99214, 99215, 99204, and 99205), I concluded that there wasn’t a significant difference in pass/fail rates between 2019, 2020, and 2021. What does that mean? In general, it means that the risk hasn’t changed. For example, if we were to see an increase in fail rates over time, it would indicate an increase in risk, because more of the upper-level codes would have been coded in error. If the fail rates were significantly lower, it might indicate that risk was also lower, since an audit would result in a null finding. But because they are mostly the same, it would indicate that risk levels are likely the same, as well. What does this mean for the practice? It means that their compliance strategy should remain the same, when it comes to their efforts in risk-based reviews on their providers. 

One notable change was the ratio of under-coding to over-coding year over year for the mid-level codes (99213 and 99203). For 99213, over-coding was recorded 45 percent less than in 2020, with reporting of under-coding increasing by 58 percent. For 99203, while the under-coding reporting was about the same, reporting of under-coding was down by almost three-quarters. I suspect this means that in the next reporting period, we will see an even greater increase in the use of these upper-level codes.

My conclusion to all of this is that while utilization of upper-level visit codes will continue to increase, risk will likely remain stable, if future audits confirm what we have seen over the first half of 2021. All in all, maybe it really is much ado about nothing!

And that’s the world according to Frank.

Program Note: Listen to Frank Cohen report this story live during the nex edition of Monitor Mondays, 10 Eastern.

Facebook
Twitter
LinkedIn

Frank Cohen, MPA

Frank Cohen is Senior Director of Analytics and Business Intelligence for VMG Health, LLC. He is a computational statistician with a focus on building risk-based audit models using predictive analytics and machine learning algorithms. He has participated in numerous studies and authored several books, including his latest, titled; “Don’t Do Something, Just Stand There: A Primer for Evidence-based Practice”

Related Stories

Why American Hospitals Face Benchmarking Challenges

Why American Hospitals Face Benchmarking Challenges

Many hospitals nationwide are facing significant challenges in benchmarking and quality reporting. While it may seem like these issues stem from complex clinical variations, the

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2025 Coding Clinic Webcast Series

2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

Uncover critical guidance. HIM coding expert, Kay Piper, RHIA, CDIP, CCS, provides an interactive review on important information in each of the AHA’s 2025 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 14, 2025

Trending News

Featured Webcasts

Audit-Proof Your Wound Care Procedures: Expert Insights on Compliance and Risk Mitigation

Audit-Proof Your Wound Care Procedures: Expert Insights on Compliance and Risk Mitigation

Providers face increasing Medicare audits when using skin substitute grafts, leaving many unprepared for claim denials and financial liabilities. Join veteran healthcare attorney Andrew B. Wachler, Esq., in this essential webcast and master the Medicare audit process, learn best practices for compliant billing and documentation, and mitigate fraud and abuse risks. With actionable insights and a live Q&A session, you’ll gain the tools to defend your practice and ensure compliance in this rapidly evolving landscape.

April 17, 2025
Utilization Review Essentials: What Every Professional Needs to Know About Medicare

Utilization Review Essentials: What Every Professional Needs to Know About Medicare

Dr. Ronald Hirsch dives into the basics of Medicare for clinicians to be successful as utilization review professionals. He’ll break down what Medicare does and doesn’t pay for, what services it provides and how hospitals get paid for providing those services – including both inpatient and outpatient. Learn how claims are prepared and how much patients must pay for their care. By attending our webcast, you will gain a new understanding of these issues and be better equipped to talk to patients, to their medical staff, and to their administrative team.

March 20, 2025

Rethinking Observation Metrics: Standardizing Data for Better Outcomes

Hospitals face growing challenges in measuring observation metrics due to inconsistencies in classification, payer policies, and benchmarking practices. Join Tiffany Ferguson, LMSW, CMAC, ACM, and Anuja Mohla, DO, FACP, MBA, ACPA-C, CHCQM-PHYADV as they provide critical insights into refining observation metrics. This webcast will address key issues affecting observation data integrity and offer strategies for improving consistency in reporting. You will learn how to define meaningful metrics, clarify commonly misinterpreted terms, and apply best practices for benchmarking, and gain actionable strategies to enhance observation data reliability, mitigate financial risk, and drive better decision-making.

February 25, 2025
Navigating the 2025 Medicare Physician Fee Schedule: Key Changes and Strategies for Success

Navigating the 2025 Medicare Physician Fee Schedule: Key Changes and Strategies for Success

The 2025 Medicare Physician Fee Schedule brings significant changes to payment rates, coverage, and coding for physician services, impacting practices nationwide. Join Stanley Nachimson, MS., as he provides a comprehensive guide to understanding these updates, offering actionable insights on new Medicare-covered services, revised coding rules, and payment policies effective January 1. Learn how to adapt your practices to maintain compliance, maximize reimbursement, and plan for revenue in 2025. Whether you’re a physician, coder, or financial staff member, this session equips you with the tools to navigate Medicare’s evolving requirements confidently and efficiently.

January 21, 2025

Trending News